Camouflage™ technology is a proprietary coating technology incorporating a synthetic polymer combined with a proteinaceous base layer. The coating technology is non-toxic, demonstrates excellent hemocompatibility, and endotheliazation. It is designed to reduce clotting cascade initiation and provides long term stability for use on a range of blood contacting medical devices. Camouflage™ is underpinned by solid Intellectual property (IP) to differentiate and to create value for our customers.
Camouflage™ acts by retaining a layer of the patient's non-inflammatory proteins (red blood cells and blood components) on the coating. This hemocompatible coating masks the device surface from the circulating blood, reducing the body's reaction to the foreign material. It also promotes endothelization, supporting the attachment of endothelial cells for long-term biocompatibility. Additionally, the antimicrobial properties of the coating help prevent infection, ensuring a safer and more durable implant.
Camouflage™ coating technology demonstrates superior hemocompatible performance with add endothelialization properties for a range of blood contacting devices.
Camouflage™ coating is a versatile coating that adheres to many substrates.
Camouflage™ coating is a superior thin coating, colourless to the naked eye.
Camouflage™ coating demonstrates longer term durability on a range of devices.
Camouflage™ coating technology is easy to integrate into manufacturing process.
Camouflage™ Coating demostartes excellent hemocompatibility and endothelialization performance as shown in the results below;
Viability of cells on coated and uncoated NiTi stents after 1hr semi-dynamic incubation and after 29hr static incubation.
Evaluation according ti USP<1072> Disinfectant and Antiseptics. 1Hr. contact with coating and evaluation of reduction of culture counts vs controls.
To talk to a Smart Reactors coating expert, Contact us today!
To talk to a Smart Reactor’s Coating expert, Contact us today!
Camouflage™ coating is just a few nanometres thick and is suitable for a broad range of application with the medical device space.
This super thin coating does not impede gas exchange permeability on perfusion devices and is perfect positioned for implantable devices to avoid thrombus formation and endothelialisation of surfaces for long term implants
To talk to a Smart Reactors Coating expert, Contact us today!
Camouflage™ has a crosslinking chemistry which ensures that the coating matrix is durable for long term applications with covalent bonds providing stability. This crosslinking chemistry is performed in water and does not rely on Ultra-Violet or heat. This allows us to apply a durable coating on samples with complex geometries where UV light can’t reach and where thermal stability is a concern.
For perfusion applications 28 day stability was demonstrated using 37 Deg C saline in flow to simulate physiological shear stresses and all samples remained coated supporting applications such as ECMO where long term performance is key.
To talk to a Smart Reactors Coating expert, Contact us today!
Camouflage™ coating technology does not incorporate active pharmaceutical ingredientsCamouflage™ is designed to control the interaction of the surface with the circulating blood and it retains non-inflammatory proteins and blood constituents on the surface. This interaction passivates the surface and Camouflage™ does not rely on any pharmaceutical mechanism of action while generating performance that is comparable to heparin in terms of thrombus reduction.
This simplifies the supply chain for manufacturers and provides an easier and clearer pathway to regulatory approval as it is not considered a combi-product and does not fall under Rule 14 of MDR.
To talk to a Smart Reactors Coating expert, Contact us today!
Lean Manufacturing Process
To talk to a Smart Reactors Coating expert, Contact us today!